Latest Stories
Guest Editorial
The initial reports of the near-miraculous benefits of CAR-T in pediatric acute lymphoblastic leukemia generated tremendous excitement—there was a Lazarus-like quality to these stories.
Louis Jacques
Chief clinical officer and senior vice president, ADVI Health; Former director of the Coverage and Analysis Group, Centers for Medicare and Medicaid Services
